Literature DB >> 16088301

Sitting on the evidence: what is the proper patient position for the office measurement of blood pressure?

Ari Mosenkis1, Raymond R Townsend.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16088301      PMCID： PMC8109406          DOI： 10.1111/j.1524-6175.2005.04115.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  16 in total

1.  Reproducibility of intra-arterial ambulatory blood pressure: effects of physical activity and posture.

Authors:  Marinel Cavelaars; Joke H M Tulen; Jan H van Bemmel; Paul G H Mulder; Anton H van den Meiracker
Journal:  J Hypertens       Date:  2004-06       Impact factor: 4.844

2.  The measurement of blood pressure: sitting or supine, once or twice?

Authors:  M J Jamieson; J Webster; S Philips; T A Jeffers; A K Scott; O J Robb; H G Lovell; J C Petrie
Journal:  J Hypertens       Date:  1990-07       Impact factor: 4.844

3.  Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group.

Authors:  B R Davis; J A Cutler; D J Gordon; C D Furberg; J T Wright; W C Cushman; R H Grimm; J LaRosa; P K Whelton; H M Perry; M H Alderman; C E Ford; S Oparil; C Francis; M Proschan; S Pressel; H R Black; C M Hawkins
Journal:  Am J Hypertens       Date:  1996-04       Impact factor: 2.689

4.  Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

Authors: 
Journal:  JAMA       Date:  1967-12-11       Impact factor: 56.272

5.  Body position and blood pressure measurement in patients with diabetes mellitus.

Authors:  R T Netea; L D Elving; J A Lutterman; Th Thien
Journal:  J Intern Med       Date:  2002-05       Impact factor: 8.989

6.  Australian comparative outcome trial of angiotensin-converting enzyme inhibitor- and diuretic-based treatment of hypertension in the elderly (ANBP2): objectives and protocol. Management Committee on behalf of the High Blood Pressure Research Council of Australia.

Authors: 
Journal:  Clin Exp Pharmacol Physiol       Date:  1997-02       Impact factor: 2.557

7.  Components of blood pressure and risk of atherothrombotic brain infarction: the Framingham study.

Authors:  W B Kannel; T R Dawber; P Sorlie; P A Wolf
Journal:  Stroke       Date:  1976 Jul-Aug       Impact factor: 7.914

8.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

9.  Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.

Authors:  B Dahlöf; R B Devereux; S Julius; S E Kjeldsen; G Beevers; U de Faire; F Fyhrquist; T Hedner; H Ibsen; K Kristianson; O Lederballe-Pedersen; L H Lindholm; M S Nieminen; P Omvik; S Oparil; H Wedel
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

10.  Both body and arm position significantly influence blood pressure measurement.

Authors:  R T Netea; J W M Lenders; P Smits; Th Thien
Journal:  J Hum Hypertens       Date:  2003-07       Impact factor: 3.012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.